Illustrative exposure model
Check whether better absorption can solve the exposure problem
Suppose an oral candidate has 90% absorption, 57% survival through intestinal first-pass loss and 80% survival through hepatic first-pass loss. BioTwin’s oral-fraction calculation multiplies these inputs to give 41% modeled systemic availability. The next question is which assumption offers meaningful room to improve.
- 41%Starting scenario
0.90 × 0.57 × 0.80 = 0.4104.
- 46%Perfect absorption
Hold first-pass survival fixed; raise absorption to 1.00.
- 72%No intestinal first-pass loss
Hold absorption and hepatic survival fixed; raise gut survival to 1.00.
- What the output changes · Under these assumptions, improving absorption alone has a limited ceiling. Intestinal first-pass loss deserves measurement before a program commits to an absorption-focused redesign. The 72% scenario is a mathematical bound; the calculation does not show that chemistry can achieve it.
- Use a standard baseline · Multiplying absorption and first-pass survival is familiar pharmacokinetic reasoning. PK-Sim and MoBi support richer mechanistic models and comparison with observations. This bounded BioTwin operation helps make an early delivery assumption explicit within an intervention investigation.
- Carry the uncertainty into the next model · Estimate absorption and intestinal and hepatic survival independently, with uncertainty. A compartment time course then needs dose, clearance, distribution and route-specific inputs. This calculation alone cannot establish tissue exposure, target engagement or a dosing regimen.
Connect the molecule to a place and a timescale
The toolkit includes bounded models for absorption, barrier passage and time-dependent compartment exposure. A program might ask whether access, retention or conversion controls the next decision. Each question needs the appropriate operation and inputs.
PK-Sim and MoBi already support mechanistic exposure modeling, data comparison and reusable model components. BioTwin’s bounded methods are aimed at exposure questions within a particular intervention investigation.
| Question | Familiar approach | BioTwin focus | Practical consequence |
|---|---|---|---|
| Modeling workflow | PK-Sim supports PBPK model creation, comparison with observations and refinement. | Investigate a defined absorption, barrier or compartment/time-course hypothesis with the available operation. | Select a model that answers the immediate program question. |
| Composition | MoBi provides reusable spatial, molecular, reaction and transport building blocks. | Consider how exposure constrains another BioTwin mechanism or candidate-design question. | Carry compatible concentration and timing assumptions into the follow-up analysis. |
| Evidence | Model credibility depends on appropriate inputs and agreement with relevant observations. | BioTwin exposure predictions likewise need molecule- and setting-specific calibration. | Use the result to choose a measurement; do not mistake it for measured bioavailability. |
The BioTwin scope here is an early computational exposure investigation. Qualification depends on the model, data and intended decision.
Make the output a decision about evidence
A sensitivity analysis can identify a permeability, clearance or distribution measurement that would change the conclusion. Computational exposure is a hypothesis until calibrated against relevant data. Measured bioavailability and clinical dose selection require additional evidence.
Follow exposure into its biological consequence
Liver-directed mechanisms, local effect and subcellular partitioning each ask what a concentration estimate means in a different setting. Joining them requires compatible compartments, timing and biological assumptions.
- Liver-directed mechanisms · Separate uptake from hepatic activation. Liver-directed mechanisms
- Local effect · Translate local and systemic exposure into a target-response question. Local effect
- Subcellular distribution · Ask where a small molecule accumulates inside the cell. Subcellular distribution